Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,677,471
+$106,944 QoQ
Shares Held
6,605
+2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.11%
of 13F equity value
Holder Rank
#2,499
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gleason Group, Inc. holds $4,846,851 across 10 Drug Manufacturers - General names. JNJ ranks #1 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
6,605 | $1,677,471 | |
| 2 | LLY |
ELI LILLY & Co
|
1,368 | $1,640,820 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
9,418 | $1,189,870 | |
| 4 | AMGN |
Amgen Inc
|
389 | $140,864 | |
| 5 | MRK |
Merck & Co., Inc.
|
899 | $115,521 | |
| 6 | ABBV |
AbbVie Inc.
|
220 | $55,360 | |
| 7 | NVS |
Novartis AG
|
62 | $9,716 | |
| 8 | AZN |
Astrazeneca PLC
|
40 | $7,584 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,677,471 | 6,605 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,570,527 | 6,425 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,322,410 | 6,390 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,175,562 | 6,340 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $961,408 | 6,294 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,076,135 | 6,489 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $987,754 | 6,830 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,118,376 | 6,901 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,022,681 | 6,997 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,158,741 | 7,325 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,171,474 | 7,474 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,155,353 | 7,418 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,236,930 | 7,473 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,149,635 | 7,417 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $1,300,850 | 7,364 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $1,195,305 | 7,317 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,281,799 | 7,221 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,271,802 | 7,176 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,219,900 | 7,131 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,144,227 | 7,085 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,094,203 | 6,642 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,084,710 | 6,600 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,032,098 | 6,558 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,206,374 | 8,103 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,136,993 | 8,085 | Shares | Sole | 2020-08-27 | |
| 2020-03-31 | $1,091,001 | 8,320 | Shares | Sole | 2020-08-27 | |
| No filing history on record for this holder in this stock. | ||||||